MCL

This microlearning provides a practical, structured approach to evaluating specimens for molecular testing using real examples and criteria drawn from laboratory practice to support confident, consistent decision-making.

Mayo Clinic Laboratories is applying AI where it helps most today, strengthening daily workflows while keeping experts firmly in control. From faster specimen intake and triage to data‑informed scheduling, first‑pass support for complex analyses, draft interpretive reporting, and reliable digital pathology quantification, teams use AI to organize information, reduce repetitive steps, and improve consistency. Human‑in‑the‑loop oversight, fit‑for‑workflow design, and regulatory‑aware communication keep the focus on safe, practical gains that benefit patients, clinicians, and laboratorians.

Plan to celebrate laboratory professionals by expressing gratitude, educating others, and energizing teams to highlight their vital role in care.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D., a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients.

In this presentation, Eoin Flanagan, M.B., B.Ch., a leading specialist in neuroimmunology at Mayo Clinic, provides a clear and clinically focused overview of autoimmune conditions that affect the developing nervous system.

Register now – June 10, 2026 - PACE / State of FL - This webinar will explore quality in the AI era—and how strong quality foundations are essential for safe, reliable and scalable AI and automation.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D., a clinical biochemical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy.

Learn more about how Precision Epilepsy testing at Mayo Clinic Laboratories enables a holistic diagnostic care experience that supports better outcomes for patients with epilepsy.

Register now – May 12, 2026 Explore how mass spectrometry serves as a powerful investigative tool

Due to the current situation affecting the region, with airport and airspace closures, Mayo Clinic Laboratories is closely monitoring shipments en route. Based on the outcome of these shipments, we will provide further direction. 

Review tips for incorporating security awareness into your daily routine, both at work and at home.

We want to make you aware of a temporary disruption at the FedEx hub in Memphis, Tennessee, due to a chemical spill, which is affecting some inbound and outbound shipments.

This month’s microlearning breaks down what cryoprecipitate is and when it’s used.